Each year around 5400 people in England and Wales die after being severely injured – for example, in a road traffic collision, or as a result of a major fall. The leading cause of preventable death following injury is uncontrolled bleeding, which usually requires immediate surgery. However, some patients die before they can reach an operating theatre.

REBOA (which stands for Resuscitative Endovascular Balloon Occlusion of the Aorta) is a new technique which could help with this.  REBOA involves passing a small inflatable balloon into the aorta (the main artery) to stop the bleeding until a patient can be taken to an operating theatre.                

The UK-REBOA study, funded by the NIHR HTA programme, aims to compare standard major trauma centre care with REBOA versus standard major trauma care alone. We expect to recruit approximately 120 patients in this study, across 10 Major Trauma Centres, over four years.

The primary outcome is mortality at 90 days.

UK-REBOA is led by Dr Jan Jansen based at the University of Alabama and HSRU, University of Aberdeen.

For more information please see the UK REBOA Study Website



Ongoing - In follow up